Evidence map›Paper›PMID 30873538›Full record

ArticleBioinformatics (Oxford, England)2019

GladiaTOX: GLobal Assessment of Dose-IndicAtor in TOXicology.

Vincenzo Belcastro, Stephane Cano, Diego Marescotti, Stefano Acali, Carine Poussin, Ignacio Gonzalez-Suarez, Florian Martin, Filipe Bonjour, Nikolai V Ivanov, Manuel C Peitsch and 1 more

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vincenzo BelcastroPhilip Morris Products S.A, PMI R&D, Neuchâtel CH, Switzerland.
Stephane CanoPhilip Morris Products S.A, PMI R&D, Neuchâtel CH, Switzerland.
Diego MarescottiPhilip Morris Products S.A, PMI R&D, Neuchâtel CH, Switzerland.
Stefano AcaliPhilip Morris Products S.A, PMI R&D, Neuchâtel CH, Switzerland.
Carine PoussinPhilip Morris Products S.A, PMI R&D, Neuchâtel CH, Switzerland.
Ignacio Gonzalez-SuarezPhilip Morris Products S.A, PMI R&D, Neuchâtel CH, Switzerland.
Florian MartinPhilip Morris Products S.A, PMI R&D, Neuchâtel CH, Switzerland.
Filipe BonjourPhilip Morris Products S.A, PMI R&D, Neuchâtel CH, Switzerland.
Nikolai V IvanovPhilip Morris Products S.A, PMI R&D, Neuchâtel CH, Switzerland.
Manuel C PeitschPhilip Morris Products S.A, PMI R&D, Neuchâtel CH, Switzerland.
Julia HoengPhilip Morris Products S.A, PMI R&D, Neuchâtel CH, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

summaryGladiaTOX R package is an open-source, flexible solution to high-content screening data processing and reporting in biomedical research. GladiaTOX takes advantage of the 'tcpl' core functionalities and provides a number of extensions: it provides a web-service solution to fetch raw data; it computes severity scores and exports ToxPi formatted files; furthermore it contains a suite of functionalities to generate PDF reports for quality control and data processing. AVAILABILITY AND IMPLEMENTATION: GladiaTOX R package (bioconductor). Also available via: git clone https://github.com/philipmorrisintl/GladiaTOX.git. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Biomedical ResearchSoftwareQuality ControlToxicology

Identifiers

PMID30873538
PMCPMC6792086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.